** Shares of Integra LifeSciences IART.O fall 4.8% to $21 premarket
** Life sciences firm posts Q4 revenue of $442.6 million, missing analyst est of $445.1 million, as per data compiled by LSEG
** Co reports Q4 adj profit of 97 cents/share vs analyst est of 86 cents/share
** IART forecasts 2025 revenue in the range of $1.65 bln to $1.71 bln
** Analysts, on average, were expecting revenue to be $1.71 bln for 2025
** Co says it expects Q1 revenue in the range of $375 mln to $385 mln, lower than analyst est. of $410.2 mln
** IART forecasts Q1 profit in the range of $0.40/share to $0.45/share
** Stock has fallen 50.7% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.